Business
Americann Partnership with C3RN Commences Cannabis Research In Massachusetts
Americann Partnership with C3RN Commences Cannabis Research In Massachusetts.
About this update from Americann Inc.
[{"type":"text","content":"- First of its Kind study in Massachusetts Designed to Research Cannabis in Legal Markets- Compliments an Ongoing National C3RN Survey with University of Massachusetts Dartmouth DENVER, CO / ACCESSWIRE / July 9, 2018 / AmeriCann, Inc. (OTCQB: ACAN), an agricultural-technology company that is developing the next generation of eco-friendly state-of-the-art greenhouse cannabis cultivation and processing properties, announced today that it is leading a research pilot study in Massachusetts. The research is led by Cannabis Community Care and Research Network (C3RN) in collaboration with UMass Dartmouth.AmeriCann, through its Preferred Partner BASK, Inc. (\"BASK\"), is conducting research studies with C3RN who is now collaborating with the UMass Dartmouth Charlton College of Business. The first study launched is an anonymous national cannabis consumer and patient survey, with a focus on the Massachusetts market.Information from this national anonymous cannabis survey will be used to improve the understanding of the consumer and patient populations as the new legal adult-use markets open across the United States and in Massachusetts. AmeriCann intends to incorporate the research finding, with a better understanding of the therapeutic benefits of cannabis, to improve product offerings including AmeriCann's Solanna line of products and will help target specific medical conditions.The survey is aimed to better understand consumer/patient demographics, attitudes, choices, methods of consumption, and knowledge of cannabis products in legal cannabis states. The study tools were designed with input from researchers at McLean Hospital/Harvard Medical School, UMass Dartmouth, and C3RN's team of researchers, data scientists, and industry experts. The study was approved by the UMass Dartmouth Institutional Review Board (IRB) and findings are planned to be published in a leading peer-reviewed journal and other leading conferences and forums.BASK is first of C3RN's study partners in Massachusetts. In addition to two other well respected Massachusetts dispensaries, C3RN is also partnering with three clinical providers for the study, Dr. Ben Caplan of the CED Foundation, Dr. Dustin Sulak, Healer.com, and Dr. Ryan Zaklin to launch the survey locally in Massachusetts.AmeriCann is developing the Massachusetts Medical Cannabis Center (MMCC), a state-of-t...